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TheTCR is a 90-kD heterodimeric glycoprotein composed of somatically rear-
ranged a andS chains (1-7) . This receptor recognizes a complex consisting of anti-
genic peptide bound to MHC glycoprotein expressed on APCs and/or target cells
(8-10) . The majority of mature T cells expressing TCRa//3 can be separated into
two populations, based on their expression ofCD4 andCD8 molecules (11, 12) . In
the mouse, the subset of T cells expressing the CD8 molecule (Lyt-2 and Lyt-3),
butlacking theCD4(L3T4) molecule, functions asCTL; their interactionwith target
cells is restricted by class I MHC antigen, whereas the CD4+ CD8 - subset con-
tains helperT lymphocytes (HTL)i whose interaction with APCs andB cells is re-
stricted by class IIMHC antigen . It is generally assumed that the process ofmatu-
ration and selection in the thymus is similar for class I and class II-restricted T
cells (13-15) .
Analysis ofTCRV gene usage in variousT cell clones andpopulationshasdemon-
strated that the sameV genes can be used by both class I-restricted or class II-re-
strictedT cells (16, 17). These results do not provide a molecular basis forthe differ-
ences between class I and class II MHC-restricted recognition ofT cells.
Recently, it has been shown that the participation of certain Vp segments in the
TCR heterodimer predisposes that receptor to class II-restricted reactivity (e.g.,
V017, V06, andVl8.1 andV/33 forI-E alloantigen or for gene products of the minor
lymphocyte stimulating locus (Mls) restricted by class II molecules) (18-21) . This
specificity assignment of certain Va+ T cells to class II MHC molecules and Mls
is supported by the general finding thatT cells bearing such V/3 gene products are
deleted from theperipheral lymphocyte pool in mouse strains expressing I-E or Mls .
Recently, weand others have shown that cells expressingV06 andV08.1 areelim-
inated from both mature T cells populations (CD4+8- and CD4-8+ ) in mice ex-
pressing Mlsa (20, 21) . This finding raises interesting questions . Since Mls responses
are mediated exclusively by CD4+8-T cells (23, 24), and sinceCD4-8+ cells, even
those expressing the potentially reactive V/3 TCR elements, are unreactive to Mls
in culture, how are such CD8+ V/3-bearingT cells deleted in vivo in Mls+ mouse
strains? Also, ifVf6 and Va8.1 endow T cells with reactivity to Mls, why are
CD4-8+ cells unreactive?
Two possibilities, not mutually exclusive, seem worth considering. First, T cells
bearingV06 or V08 elements in theirTCR might be eliminated as an early event
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in T cell maturation, either at the double-negative (CD4-8-TCR') stage or at the
double-positive (CD4'8'TCR') stage. Secondly, the nonreactivity of mature
CD4-8' Vf6' or Vf8V T cells to Mls might reflect changes in the functional
specificity of such T cells imposed by expression of CD8 molecules in the absence
of CD4 markers.
To explore a possible role of differential expression of CD4 and CD8 molecules
on the functional specificity of T cells, we have established several Va8.1' T cell
hybridomas by fusion of an HTL clone 016 (VS 8.1' CD4'8-, reactive to HY/I-Ab
and Mlsa) and a CTL line OH2 (Va8.1' CD4-8', reactive to HY/H-2D6 but not
to Mls) to two different BW5147 thymoma cell lines (an TCRa-//3- variant and
the same variant cell line expressing transfected mouse Lyt-2 molecules). Additional
variants of these hybridoma lines lacking CD4 molecules were created by selection
with anti-CD4 antibodies and complement.
We report here the specificity analyses of these cell lines and show that (a) either
the gain of CD8 or the loss of CD4 from the HTL (CD4'8-, HY/Ab, and Mlsa reac-
tive) line results in the loss of class II-restricted specificity, and (b) the loss of CD8
from the CTL (CD4-8', H-2 Y/Db reactive, and Mls nonreactive) line causes both
the loss of class I-restricted specificity and the gain of Mls reactivity by a cell line
otherwise not reactive to this molecule. These data provide direct evidence that the
CD8 molecule can have a dramatic effect on the specificity of T cells; with the cell
lines reported here, it blocks class II MHC-restricted T cell responses, and it blocks
responses to Mls by CD4- T cells.
Materials and Methods
Mice. C57BL/6, B6.C-H-26"''2, B6.C-H-26m", B10.D2, B10.BR, DBA/2, and AKR/J
mice were purchased from The Jackson Laboratory (Bar Harbor, ME).
TCell Lines andmAbs.
￿
Two male antigen-specific T cell clones derived from B6 females,
0112 (CD8', cytolytic)and 016 (CD4' noncyclic), were established and maintained in vitro
as described (25). The TCR a and (3 chain loss variant of AKR-derived thymoma cell line
BW5147 was kindly provided by Dr. W. Born (NationalJewish Center for Immunology and
Respiratory Medicine, Denver, CO). mAbs directed to the V08 TCR (MR5-2) as well as
to clonotypic determinants ofOH2 TCR (MR2-6) and 016 TCR (MR5-10) were established
as described previously (24). mAbs directed to Thy-1 (AT83), L3T4 (GK1.5), and Lyt-2 (3 .155)
were kindly provided by Dr. F W. Fitch (University of Chicago, Chicago, IL) (26).
TCell Stimulation Assay.
￿
For antigen-induced proliferation assays, T cells (2 x 104) were
cultured with irradiated (2,000 rad) spleen cells (5 x 105) in flat-bottomed microtiter plates
in a final volume of 200 Ad in 5% FCS DMEM. After 72 h of culture and a 6-h pulse with
1 jXi of [3H]thymidine, cultures were harvested onto filters and counted. T cell hybridomas
were tested for their ability to produce IL-2 upon stimulation with various spleen cells as
described previously (27). In brief, 105 hybridoma cells were cultured with 5 x 105 stimu-
lator spleen cells (2,000 rad irradiated) in a final volume of 200 Ftl in 5% FCS DMEM in
the presence or absence of mAb (1/8, vol/vol). For the stimulation of the hybridomas with
mAbs directed to the TCR, culture plates were coated with mAb overnight and T cells were
incubated without stimulator spleen cells. After 24 h of incubation, culture supernatants were
harvested and tested for the presence of IL-2 using the IL-2-dependent T cell line CTLL.
Results are presented as units of IL-2 per milliter of culture supernatant (28).
Lyt-2 Gene Transfection and the Establishment of T- THybridomas.
￿
A plasmid containing the
Lyt-2 gene and bacterial gpt gene (pCA208) (29) was kindly provided by Dr. B. Malissen
(INSERM-CNRS de Marseille-Luminy, France). The plasmid (20 pg) and 5 x 106 TCR-
a-/S- BW5147 cells were suspended in 0.5 ml PBS (pH 7.4) and electroporated using a BTX
100 power supply (BTX, San Diego, CA). The cells were cultured in complete culture mediumKANAGAWA AND MAKI
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in 96-well microtiter plates. After 48 h of incubation, cells were selected for the expression
ofthe transfected gene using mycophenolic acid (2 Rg/ml), xanthine (250 p,g/ml), and hypo-
xanthine (15 leg/ml). Growing cells were expanded, selected for the expression of Lyt-2 gene
expression and cloned. T-T cell hybridomas were established as described previously (30).
For the selection of the BW Lyt-2 x T cell clone hybridomas, since the transfected gpt gene
confers on the thymoma cell line resistance to HAT selection, hybridomas cultured in HAT
medium were selected for the expression of both Thy-1.1 (BW thymoma origin) and Thy-1 .2
(T cell clone origin) alloantigens by extensive panning, cloned, and tested for the expression
of surface TCR and Lyt-2 alloantigen. CD4- variants of hybridomas were established by
two cycles of anti-mouse CD4 mAb plus complement treatment and cloning.
Flow Cytometry Analysis.
￿
The analysis was performed as described previously (25). In brief,
cells (106) were incubated with 100 pl of hybridoma culture supernatant for 30 min on ice
followed by adding FITC-conjugated second reagent for an additional 30-min incubation.
Stained samples were analyzed using FACScan analyzer. Control samples were prepared in
the same manner but without the first mAb.
Results
Mls Reactivity of CD4'8- and CD4-8' T Cell Clones.
￿
Clone 016, CD4'8-, recog-
nizes male antigen (HY) in the context of I-Ab class II MHC, and clone OH2,
CD4-8', recognizes HY antigen in the context of Db class I MHC antigen. Both
clones express the V08.1 TCR gene product as part of the surface receptor as deter-
mined by nucleotide sequencing of TCR cDNAs (Kanagawa, 0., and Y Takagaki,
unpublished data) and staining with V08-specific mAbs (Table I). Both clones ex-
hibited strong proliferative responses upon stimulation with B6 (H-2b) male spleen
cells but not with B6 female spleen cells (Table 1). The restriction specificity of both
clones was more precisely defined by the finding that 016 T cells failed to respond
to bm12 (I-Ab mutant) male stimulator cells, and the OH2 T cells did not respond
to bm14 (Db mutant) male spleen cells (Table I).
When 016 and OH2 cells were stimulated with spleen cells from various strains
of mice, it was found that 016, but not OH2 cells, could respond to stimulator cells
from Mlsa-positive strains, even those with different H-2 haplotypes, but not to
stimulators from Mlsa-negative strains (Table I). The Mlsa specificity of the 016
T cell clone was confirmed by using various stimulatorcells expressingdifferent MHC
and Mls antigens (data not shown).
Antigen-specific proliferative responses of OH2 and 016 T cells were inhibited
by either mAb MR5-2 (antiV/3 8) or the anticlonotypic mAbs, MR2-6 (specific for
OH2 TCR) and MR5-10 (specific for 016 TCR) (Table I). These data clearly dem-
onstrate that (a) the CD4'8- clone 016 is reactive to H-Y + Ab and Mls, while
the CD4-8' clone OH2 is reactive only to HY + Db, and (b) TCR molecules
identified by antiV08 and anticlonotypic mAbs are involved in these responses to
Mls and HY.
Antigen Specificity of T-THybridomas.
￿
To better understand the basis for the failure
of OH2 T cells to respond to Mlsa antigen, a panel of T cell hybridomas was gener-
ated with OH2 and 016 T cells. The parent cell line used for the fusion was a variant
of the BW5147 cell line (ot-(3-BW) that lacks expression of both endogenous cr and
achains ofthe TCR due to irradiation-induced deletions ofthese genes. Both OH2
and 016 cell lines were fused with the a-o- BW cell line and selected in HAT
medium. Growing hybridomas were cloned under limiting dilution conditions and
selected for expression of either OH2 or 016 derived TCR.904
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When these hybridomas were tested for antigen specificity by measuring IL-2
production upon stimulationwithspleen cells, hybridomaKR3, establishedbyfusing
016 T cells with the a-fl- BW cell line, was found to exhibit the same regimen
specificity as the original 016 T cell clone, namely to H-Y + I-Ab and Mls (Table
II A). In contrast, the hybridoma KV24, established by fusing the CTL clone OH2
with BW, was incapable ofproducing IL-2 upon stimulation with B6 male spleen
cells, but surprisingly it showed response to Mls (Table II A). This was confirmed
in another experiment where KV24 failed to show alloreactivity to B10.BR (H-2k,
Mlsb), but showed good responses to AKR/J, RF/J, and CBA/J strains expressing
Mlsa antigen and the same H-2k haplotype (result not shown).
To determinewhether thisMls-specific response ofthe KV24hybridomawasmedi-
ated by the TCR of the original OH2 CTL clone, hybridomas were stimulated by
AKR spleen cellsinthe presence or absenceoftheantiTCR mAbs(MR5-2, MR2-6
and MR5-10). As shown in the Table II B, the Mlsa-specific responses ofboth KV24
and KR3 were inhibited by mAb MR5-2 specific for the V#8 TCR. The finding
that theanticlonotypic mAb MR2-6 that isdirectedto the OH2 TCRwas alsocapable
ofinhibiting the Mlsa-specific response ofthe KV24 hybridoma, but not KR3, in-
dicated that the TCR ofthe CTL clone OH2 was responsible forthe Mlsa specificity
of the KV24 hybridoma.
The phenotype of hybridomas KV24 and KR3 were analyzed by surface im-
munofluorescent staining (Table II C). Hybridoma KR3 was found to express the
CD4 molecule; however, KV24, derived from the CD8+ OH2 cell line, was found
to be negative for the expression ofthe CD8 molecule. A requirement forCD8 mol-
TABLE II
Antigen Speciciy and Surface Phenotype of the Hybridonuts
The antigen-specific IL-2 production by the T cell hybridomas and inhibition
of antigen-specific T cell response with mAbs was measured as described in
Materials and Methods. Surface phenotype of the hybridomas was analyzed
by immunofluorescence staining using the mAbs described in Materials and
Methods.
' Irradiated spleen cells.
I IL-2 units per milliliter ofculture supernatant. The minimum detectable unit
in our assay was 1 U/ml.
Stimulation with
Hybridomas Parental cell lines B6 male' B6 female BIO.BR AKR
A KV24 OH2 x BW a-0- <lI <1 <1 18
KR3 016 x BW a-0- 22 <1 <1 142
Stimulation with
AKR + AKR + AKR +
AKR MR5-2 MR2-6 MR5-10
B KV24 13 <1 <1 11
KR3 110 4 98 7
Surface phenotype
Thy-1.2 Lyt-2 L3T4 MR5-2 MR2-6 MR5-10
C KV24 + - - + + -
KR3 + - + + - +906
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ecules in class I-restricted antigen recognition byCTL has been well documented,
thus the failure ofKV24 to respond to B6 male spleen cells may be due to the lack
of expression ofCD8.
Establishmentof V,88.1* Hybridomas Expressing Different CD4JCD8Phenotypes.
￿
Given
the special circumstances of the KV24 hybridoma, lackingCD8 and the concomi-
tant appearance of Mls reactivity, we decided to assess the role of CD8 molecule
on the functional antigen specificity of the hybridomas. First theCD8 gene was in-
troduced intoan a-ß- BW cell line by gene transfection . CD8+ BW5147 cells(BW
CD8) were then used to establish hybridomas with the OH2 CTL (NA3 hybrid-
omas) and 016 HTL (NB hybridoma) . The NA3 hybridoma (OH2 CTL x BW
CD8) cells were cloned and shown to express both theCD8 molecule andTCR de-
rived from OH2 (Fig. 1 A) . TheNB hybridoma(016 x BW CD8) NB were tested
in a similar manner and shown to be CD8+ and TCR+ (Fig. I B).
effect ofCD8 expression in the absence of theCD4 molecule on
A KV24 NA3
NONE
Lyt-2
TCR
FLUORESCENCE INTENSITY
(LOG 10)
Flow cytometry
analysis ofthe hybridomas and
their immunoselected variants.
(A) OH2 x BW5147 (KV24)
and OH2 x BW Lyt-2 (NA3)
were analyzed for the surface
phenotypes using anti-Lyt-2
(3.155), anti-L3T4 (GK 1.5),
and antiTCR (MR2-6) anti-
bodies. (B) See facing page .016
x BW5147 (KR3)and 016 x
BW Lyt-2 (NB9 .1) and their im-
munoselected L3T4 - variants,
KR3N and NB7.3, were ana-
lyzed in the same manner but
usingMR5-10 as an antiTCR
antibody.B
NONE
Lyt-2
L3T4
TCR
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HTL x BW hybridomas, the KR3 (CD8-, CD4+, TCR+) and NB hybridomas
were treated with anti-CD4 mAb and complement. Clones KR3N (CD4-, CD8-,
TCR+) and NZB7.3 (CD8+, CD4-, TCR+) were selected (Fig. 1 B). The amount
ofTCR expressed on these selected hybridomas was found to be significantly less.
The functional antigen specificity ofthese variousmanipulated V08.1 hybridomas
expressing the HTL 016 and CTL 0112 TCR was determined in IL-2 assays by
stimulation withsplenic cellsfrom severaldifferent strains(Table III). Thedatacan
be summarized as follows: First, for hybridomas derived from 0112 (CD4-8+,
HY/Db reactive, and Mls nonreactive), theloss ofCD8 (KV24, CD4-8-) is accom-
panied by the lossofclass I-restricted reactivity and thegainofMls reactivity. Thus,
as expected, loss ofCD8 causes diminished responses to class I-restricted antigen,
but it also causes the appearance of a new reactivity to Mls. The introduction of
CD8 molecule into hybridoma (NA3) restored the class I-restricted HY response,
but resulted in the loss of Mls reactivity.
Second, for hybridomas derived from the dual reactive 016 clone (CD4+8-,
HY/I-Ab and Mls reactive), either the loss of CD4 (KR3N, CD4-8-), or the gain
ofCD8 (NB9.1, CD4+8+) causes nonreactivity to a class II MHC-restricted antigen.
In addition, for cells bearing this TCR, the presence ofCD8 in the absence ofCD4
blocks Mls responses.
KR3
￿
NB7.3
￿
NB9.1
￿
KR3. N
FIGURE 1 .
￿
(B) See facing page for legend.
FLUORESCENCE INTENSITY
(LOG 10)
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TABLE III
Effect of CD4 and CD8 Phenotype on the Antigen Specificity of the Hybridomas
Hybridomas were stimulated with either irradiated spleen cells or anti-TCR mAb (MR2-6
and MR5-10 for OH2 and 016 hybridomas, respectively) fixed onto the culture plates and
amount of IL-2 produced was measured as described in the Materials and Methods.
` IL-2 U/ml of culture supernatant.
Discussion
The experiments reported here explore the effects on the functional specificity
of two different Vf8.1 C57BL/6 T cell clones caused by manipulating theirexpres-
sion of CD4 and CD8 molecules. One of these V08.1 clones, a HTL (016), is
CD4'8- and is reactive to H-Y restricted by MHC class II molecules (I-Ab) and
is also Mlsa reactive; the second V08.1 clone, a CTL line (OH2), is CD4-8' and
reacts only to HY restricted by MHC class I (Db). These clones were fused to the
TCRa-/a_ variant of BW5147 that extinguishes CD8 expression, or to a re-
engineered TCRa-//3-, CD8' variant ofBW5147, in which case resulting hybrid-
omas continued to express CD8. Loss ofCD4 expression was caused by selection
in culture in the presence ofanti-CD4 antibodies and complement. At each step
in the manipulation of the CD4/CD8 phenotype, the resulting hybridomas were
assessed for reactivity to HY/I-Ab, HY/Db, Mls, and to triggering by immobilized
mAbs specific for V08 and clonotypic markers of the TCR ci,o chains.
The results presented in Table III demonstrate the effect of altering CD4/CD8
phenotypes on the functional specificity of these cells. First, the results show that
either the loss ofCD4 (KR3N, CD4-8-) or the gain ofCD8 (NB9.1, CD4'8') by
HTL CD4'8-, HY/I-Ab, Mls reactive cells with the 016 TCR is accompanied by
the loss ofreactivity to HY/I-Ab while Mls responses are retained. Subsequent loss
of CD4 from NB9.1 (CD4'8') in the NB7.3 line (CD4 -8') loses reactivity to both
antigens. From these findings we conclude that (a) the presence ofCD4 is required
for class II-restricted reactivity, but not for Mls responses; (b) responses to class II
MHC-restricted antigens, but not to Mls, are inhibited in CD4' cells by the pres-
ence of CD8 molecules; and (c) the presence ofCD8 in a CD4- cell extinguishes
responses both to class II-restricted antigens and Mls.
Second, with V08.1 cells of the CD4-8' phenotype, bearing the OH2 CTL
receptor, reactive to HY/Db only, the loss ofCD8 is accompanied, as expected, by
the loss ofclass I MHC-restricted specificity, but what may not have been expected
is that loss ofCD8 in this otherwise Mls nonreactive cell line also endowed it with
a new reactivity to Mls. From this findingwe conclude, as have others, that class I-
Hybridomas
CD4/CD8
phenotype Anti-TCR Ab
Stimulation
B6 male B6
with
female B10.BR AKR
OH2 hybridomas
KV24 CD4-CD8- 48` <1 <1 <1 54
NA3 CD4"CD8' 17 3 <1 <1 <1
016 hybridomas
KR3 CD4+CD8- 227 38 <1 <1 178
NB7.3 CD4-CD8+ 54 <1 <1 <1 1
NB9.1 CD4'CD8* 127 <1 <1 <1 137
KR3N CD4-CD8- 114 <1 <1 <1 76KANAGAWA AND MAKI
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restricted responses rely heavily on CD8, and that CD8 blocks Mls responses in
CD4- T cells, as discussed above for 016 TCR.
The results ofthe present analyses correlating specificity of V08.1+ Tcells with
their CD4/CD8 phenotypes involve only a limited number of different Va8.1'
TCR. Consequently, it isnot yetcertainwhetherthey apply to all TcellsusingV08.1
TCR. Nevertheless, we have recently examined three additional CTL CD4-8'
clones and hybridomas derived from them; allexpressedV06 orV08.1, and all were
reactive to class I-restricted antigens but not to Mls. By contrast, ofseveral HTL
CD4+8-, class II MHC-restricted clones expressing V/36 or Va8.1, all were reac-
tive to Mls (Kanagawa, 0., unpublished data).
In this report, we have found thatthe TCR densityon thehybridomas expressing
different CD4, CD8 phenotypes differs significantly and this TCR density differ-
ence might affect the antigen reactivity of the hybridomas. However, CD4-8- hy-
bridomas expressing varyingdegree ofOH2 TCR exhibited similar Mls reactivity
(Kanagawa, 0., unpublished data), suggesting the minor effect ofTCR density on
Mls reactivity of 0142 TCR.
IfV08.1+ CD4-8' TCR cells are not reactive to Mls, how are they deleted in
Mlsa positive mice? Studies ofMacDonald and his colleagues (31) have shown that
treatment ofneonatal Mlsa-positive mice with anti-CD4 mAb prevents deletion of
V06' T cells, including those ofthe CD8+ phenotype. They concluded that V06
CD8+ T cells might derive from immature CD4+8+ precursors, and they suggested
that Mls-reactive cells could be deleted at this double-positive stage during thymic
developmentin Mls-positive mousestrains. Theresultspresentedinthispaper, showing
that V08.1+ cells ofthe CD4+8+ and CD4-8- phenotypes, but not CD4-8' T cells,
are Mls reactive, indicate that negative selection ofsuch cells might occur during
the double-positive stage, as suggested, or at an even earlier double-negative stage,
but probably could not occur in the more mature CD4-8' single-positive stage.
Similarconclusionswere reached by von Boehmer andhis colleaguesusing trans-
genic mice expressing TCR a and a chains (32). The majority of T cells in these
mice were potentially reactive to HY/Db. Three important observations were made
in comparing male and female H-26 mice expressing these transgenis: males showed
(a) a marked reduction (ti90%) in numbers of CD4+8+ thymocytes, (b) reduced
numbers ofCD4'8- cells, and (c) the presence oftransgene-expressing T cells with
very low levels of CD8 expression. The common feature ofboth these examples is
that CD4-8' V06 T cells are deleted in Mls+ strains, and CD4+8- VR8+ T cells
are deleted in the male transgenic mice, but neithercell population shows any reac-
tivity to its respective antigen.
Thepointtobe emphasized here isthat the functional specificity ofagiven TCR
a/(3+ cell, consequently its selectivity in the thymus, depends on its CD4/CD8
phenotype, and its reactivity to a particular ligand can be changed by altering ex-
pression ofCD4 orCD8 moleculeswithout directly changing itsreceptor molecules.
Several examples of this are presented in this paper: (a) starting from a CD4+8-
clone, loss of CD4 or the gain of CD8 extinguishes class II MHC reactivity, but
Mls responses remain intact; (b) subsequent loss of CD4 from a CD4+8+ clone
causes loss ofMls reactivity; and (c) loss ofCD8 from a CD4-8' clone blocks class I
reactivity but it also causes the appearance of Mls reactivity.
The involvement ofCD8moleculesin class I-restricted recognitionhasbeen demon-910
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strated in the past by experiments involving blocking withanti-CD8 antibodies (33,
34), transfection with CD8 genes (29, 35), and direct cell adhesion studies(36). The
current study shows yet another effect o£ the presence ofCD8 molecules on T cell
specificity : in double-positive CD4'8' T cells they inhibit class II-restricted re-
sponses while allowing recognition of MIS, and in CD4-8' T cells, they block MIS
recognition .
Justhow this occurs is not clear, but the following scenario seemsworth considering .
At least with the pair ofVß8.1 TCR used in this study, the requirement forCD4
in TCR-class II interactions might be for avidity sufficient to cause triggering by
esence ofCD8 molecules interferes with this interaction, per-
haps by competing with CD4 for acommon interaction site . The avidity ofTCR
MIS interactions seems to override CD8 inhibition in the presence of CD4 mole-
cules, but not in their absence.
We do not know whether the double specificity ofa single TCR is true for every
CTLTCR using the class II or MIS reactive Vß chains (Vß 3, 6, 8.1, and 17a) as
part of the surface receptor for antigen . Manipulation ofCD4/8 phenotypes of T
cell clones andhybridomas bymethods described in this report and further analysis
of antigen specificity of these manipulated hybridomas is now underway to resolve
these puzzling and fundamenal issues of T cell recognition .
Summary
T cell hybridomas were established by fusing a CD8' Vß8.1' CTL clone and a
CD4' Vß8.1' helperT lymphocyte (HTL) clone to the thymoma cell line BW5147 .
In contrast to theHTL x BW hybridomas,which retain the same antigen specificity
as the originalTcell clone, theCTL x BW hybridomas lost the classIMHC-restricted
antigen response but acquired a new specificity to MIsa antigen . MIsa reactivity of
CTL x BW hybridomas was shown to be mediated by the CTL TCR as assayed
by inhibition usingan anticlonotypic antibody to theCTLclone. Sincehybridomas
established with BW5147 lose CD8 expression, we have introduced theCD8 mole-
cule into CTL x BW5147 hybridomas by gene transfection . The CD8' Vß8.1' hy-
bridoma was no longer capable of reacting to Mlsa antigen but exhibited the same
ificity as theparentalCTLclone. Furthermore, thepresence of the trans-
fected CD8 molecule in the HTL x BW hybridomas was found to be inhibitory
to class II MHC-restricted antigen reactivity. These results demonstrate that, be
sides its role in increasing the overall avidity ofTcell-class I MHC/antigen interac-
inhibitsTcell-class IIMHC gene product/antigen interac-
tion. This negative effect oftheCD8 moleculeonaclass II MHC-restricted response
may account for the failure ofCD8' T cells using either Vß8.1 or Vß6, which im-
part reactivity to the MIsa antigen on CD4'T cells, to respond to the MIsa antigen.
The authors would like to thank Dr . B . Malissen for the plasmid pCA 208 containing the
Lyt-2 gene, Dr.W . Born forTCR-negative variantBW cell line, Drs. B . E . Torbett andD . B.
Wilson for reading this manuscript, and Ms. C. Dickson for manuscript preparation .
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